dexchlorpheniramine,
dexchlorpheniramine maleate,
dexchlorpheniramine maleate (1:1), (+-)-isomer,
dexchlorpheniramine maleate (1:1), (R)-isomer,
dexchlorpheniramine maleate (1:1), (S)-isomer,
dexchlorpheniramine monohydrochloride,
dexchlorpheniramine sodium maleate (1:1),
dexchlorpheniramine, (+-)-isomer,
dexchlorpheniramine, (R)-isomer,
dexchlorpheniramine, monohydrochloride, (S)-isomer,
Dexclor,
dexclorfeniramine,
dextrochlorpheniramine maleate,
Polaramin,
Polaramine,
Polargen TD,
Polaronil,
Dexchlorpheniramine maleate,
2438-32-6,
(+)-Chlorpheniramine maleate,
d-Chlorpheniramine maleate,
Dexchloropheniramine maleate,
Dexchlorpheniramine (maleate),
S-(+)-Chlorpheniramine maleate salt,
UNII-B10YD955QW,
Dextrochlorpheniramine maleate,
B10YD955QW,
CHEBI:4465,
Dexchlorpheniramine maleate [USP],
Fortamine,
MFCD00079046,
Chlorpheniramine d-form maleate,
S-(+)-Chlorpheniramine maleate,
Dexchlorpheniramine maleate (USP),
EINECS 219-450-6,
(2Z)-but-2-enedioic acid; [(3S)-3-(4-chlorophenyl)-3-(pyridin-2-yl)propyl]dimethylamine,
SR-01000075763,
Polamin,
polar amine,
(+)-2-(p-Chloro-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate (1:1),
Rescon JR,
Rescon MX,
(Z)-but-2-enedioic acid;(3S)-3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine,
Mylaramine (TN),
Polaramine (TN),
Dexchlorpheniraminmaleat,
AC1NQXZE,
(S)-3-(4-chlorophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine maleate,
MLS001401384,
SCHEMBL119500,
2-[p-Chloro-|A-[2-(dimethylamino)ethyl]benzyl]pyridine Maleate,
AC1Q71E6,
CHEMBL1200927,
DeXchlorpheniramine Maleate, USP,
(gamma-(4-Chlorophenyl)-pyridine-2-propyl)(dimethyl)ammonium hydrogen (Z)-maleate,
DBAKFASWICGISY-DASCVMRKSA-N,
Pyridine, 2-(p-chloro-alpha-(2-(dimethylamino)ethyl)benzyl)-, maleate (1:1), (+)-,
(S)-Chlorpheniramine Maleate Salt,
HMS2052E15,
HMS2233I15,
HMS3260F10,
2-Pyridinepropanamine, gamma-(4-chlorophenyl)-N,N-dimethyl-, (S)-, (Z)-2-butenedioate (1:1),
d-Chlorpheniramine maleate (JP17),
HY-B1062,
Tox21_500264,
AKOS015962825,
ACM2438326,
CCG-101121,
CS-4618,
DB09555,
LP00264,
NC00371,
NCGC00093722-01,
NCGC00093722-02,
NCGC00093722-03,
NCGC00260949-01,
AC-19009,
AN-20814,
AS-17464,
CPD000471617,
SAM001246557,
SMR000471617,
EU-0100264,
V0236,
C 4915,
C07783,
D00668,
438D326,
SR-01000075763-1,
SR-01000075763-4,
UNII-V1Q0O9OJ9Z component DBAKFASWICGISY-DASCVMRKSA-N,
(gammaS)-gamma-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine maleate,
(S)-|A-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine maleate salt,
(S)-gamma-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine maleate salt,
Dexchlorpheniramine maleate, European Pharmacopoeia (EP) Reference Standard,
(|AS)-|A-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine (2Z)-2-Butenedioate,
(3S)-3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine; maleic acid,
Dexchlorpheniramine maleate, United States Pharmacopeia (USP) Reference Standard,
(Z)-but-2-enedioic acid; (3S)-3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine,
Polaramine,
Mylaramine,
Phendextro,
Isomerine,
Phenamin,
Polaramin,
Polaronil,
Chlorpheniramine maleate,
Polaramine Expectorant,
D05ZGQ,
C20H23ClN2O4,
DEXCHLORPHENIRAMINEMALEATE,
C16H19ClN2.C4H4O4,
Dexchlorpheniramine maleate [USAN],
CID5281070,
C16-H19-Cl-N2.C4-H4-O4,
B1556,
A10205,
113-92-8,
[gamma-(4-chlorophenyl)-pyridine-2-propyl](dimethyl)ammonium hydrogen (Z)-maleate,
Pyridine, 2-[p-chloro-.alpha.-[2-(dimethylamino)ethyl]benzyl]-, maleate(1:1), (S)-,
2-Pyridinepropanamine, .gamma.-(4-chlorophenyl)-N,N-dimethyl-, (.gamma.S)-, (2Z)-2-butenedioate (1:1),
2-Pyridinepropanamine, .gamma.-(4-chlorophenyl)-N,N-dimethyl-, (S)-, (Z)-2-butenedioate (1:1),